Daiwa Securities Group’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-209
| Closed | -$36K | – | 1477 |
|
|
2021
Q3 | $36K | Buy |
209
+89
| +74% | +$15.3K | ﹤0.01% | 1076 |
|
|
2021
Q2 | $15K | Hold |
120
| – | – | ﹤0.01% | 1027 |
|
|
2021
Q1 | $16K | Buy |
120
+7
| +6% | +$933 | ﹤0.01% | 1021 |
|
|
2020
Q4 | $14K | Sell |
113
-225
| -67% | -$27.9K | ﹤0.01% | 997 |
|
|
2020
Q3 | $38K | Buy |
338
+38
| +13% | +$4.27K | ﹤0.01% | 948 |
|
|
2020
Q2 | $27K | Hold |
300
| – | – | ﹤0.01% | 1001 |
|
|
2020
Q1 | $27K | Hold |
300
| – | – | ﹤0.01% | 985 |
|
|
2019
Q4 | $16K | Sell |
300
-29
| -9% | -$1.55K | ﹤0.01% | 1023 |
|
|
2019
Q3 | $13K | Hold |
329
| – | – | ﹤0.01% | 1009 |
|
|
2019
Q2 | $14K | Hold |
329
| – | – | ﹤0.01% | 1025 |
|
|
2019
Q1 | $15K | Buy |
329
+79
| +32% | +$3.6K | ﹤0.01% | 996 |
|
|
2018
Q4 | $11K | Hold |
250
| – | – | ﹤0.01% | 986 |
|
|
2018
Q3 | $14K | Hold |
250
| – | – | ﹤0.01% | 1003 |
|
|
2018
Q2 | $12K | Hold |
250
| – | – | ﹤0.01% | 1037 |
|
|
2018
Q1 | $10K | Buy |
+250
| New | +$10K | ﹤0.01% | 1023 |
|